Nicholas signs R&D deal with Pfizer

Nicholas Piramal India has signed a research and development (R&D) services agreement with Pfizer International LLC.

According to a release issued by Nicholas Piramal to the BSE today, the company will provide process, development and scale-up services to Pfizer's animal health division from its facilities in India.

"The contract is for a period of seven years, and is renewable thereafter," the release added.